Autoinflammatory Keratinization Diseases-The Concept, Pathophysiology, and Clinical Implications

Overview

Journal Clin Rev Allergy Immunol

Specialty Allergy & Immunology

Date 2023 Dec 16

PMID 38103162

Authors

Leszek Blicharz

Joanna Czuwara

Lidia Rudnicka

Antonio Torrelo

Affiliations

Soon will be listed here.

Abstract

Recent advances in medical genetics elucidated the background of diseases characterized by superficial dermal and epidermal inflammation with resultant aberrant keratosis. This led to introducing the term autoinflammatory keratinization diseases encompassing entities in which monogenic mutations cause spontaneous activation of the innate immunity and subsequent disruption of the keratinization process. Originally, autoinflammatory keratinization diseases were attributed to pathogenic variants of CARD14 (generalized pustular psoriasis with concomitant psoriasis vulgaris, palmoplantar pustulosis, type V pityriasis rubra pilaris), IL36RN (generalized pustular psoriasis without concomitant psoriasis vulgaris, impetigo herpetiformis, acrodermatitis continua of Hallopeau), NLRP1 (familial forms of keratosis lichenoides chronica), and genes of the mevalonate pathway, i.e., MVK, PMVK, MVD, and FDPS (porokeratosis). Since then, endotypes underlying novel entities matching the concept of autoinflammatory keratinization diseases have been discovered (mutations of JAK1, POMP, and EGFR). This review describes the concept and pathophysiology of autoinflammatory keratinization diseases and outlines the characteristic clinical features of the associated entities. Furthermore, a novel term for NLRP1-associated autoinflammatory disease with epithelial dyskeratosis (NADED) describing the spectrum of autoinflammatory keratinization diseases secondary to NLRP1 mutations is proposed.

References

Gruber C, Calis J, Buta S, Evrony G, Martin J, Uhl S . Complex Autoinflammatory Syndrome Unveils Fundamental Principles of JAK1 Kinase Transcriptional and Biochemical Function. Immunity. 2020; 53(3):672-684.e11. PMC: 7398039. DOI: 10.1016/j.immuni.2020.07.006. View

Campbell P, Morton P, Takeichi T, Salam A, Roberts N, Proudfoot L . Epithelial inflammation resulting from an inherited loss-of-function mutation in EGFR. J Invest Dermatol. 2014; 134(10):2570-2578. PMC: 4090136. DOI: 10.1038/jid.2014.164. View

Genovese G, Moltrasio C, Cassano N, Maronese C, Vena G, Marzano A . Pustular Psoriasis: From Pathophysiology to Treatment. Biomedicines. 2021; 9(12). PMC: 8698272. DOI: 10.3390/biomedicines9121746. View

Marrakchi S, Puig L . Pathophysiology of Generalized Pustular Psoriasis. Am J Clin Dermatol. 2022; 23(Suppl 1):13-19. PMC: 8801405. DOI: 10.1007/s40257-021-00655-y. View

Onoufriadis A, Simpson M, Pink A, Di Meglio P, Smith C, Pullabhatla V . Mutations in IL36RN/IL1F5 are associated with the severe episodic inflammatory skin disease known as generalized pustular psoriasis. Am J Hum Genet. 2011; 89(3):432-7. PMC: 3169817. DOI: 10.1016/j.ajhg.2011.07.022. View

Watts P, Khachemoune A . Subcorneal Pustular Dermatosis: A Review of 30 Years of Progress. Am J Clin Dermatol. 2016; 17(6):653-671. DOI: 10.1007/s40257-016-0202-8. View

Szekanecz Z, McInnes I, Schett G, Szamosi S, Benko S, Szucs G . Autoinflammation and autoimmunity across rheumatic and musculoskeletal diseases. Nat Rev Rheumatol. 2021; 17(10):585-595. DOI: 10.1038/s41584-021-00652-9. View

Crow Y, Stetson D . The type I interferonopathies: 10 years on. Nat Rev Immunol. 2021; 22(8):471-483. PMC: 8527296. DOI: 10.1038/s41577-021-00633-9. View

Li M, Lay K, Zimmer A, Technau-Hafsi K, Wong J, Reimer-Taschenbrecker A . A homozygous p.Leu813Pro gain-of-function NLRP1 variant causes phenotypes of different severity in two siblings. Br J Dermatol. 2023; 188(2):259-267. DOI: 10.1093/bjd/ljac039. View

10.

Seely M, Jackson K, Meeker A, Daluvoy M . Case Series of Patients With Hereditary Benign Intraepithelial Dyskeratosis. Cornea. 2022; 41(11):1451-1454. DOI: 10.1097/ICO.0000000000003085. View

11.

Sugiura K . Role of Interleukin 36 in Generalised Pustular Psoriasis and Beyond. Dermatol Ther (Heidelb). 2022; 12(2):315-328. PMC: 8850521. DOI: 10.1007/s13555-021-00677-8. View

12.

Samuelov L, Sarig O, Malovitski K, Bergson S, Meijers O, Shouval D . Neonatal inflammatory skin and bowel disease type 1 caused by a complex genetic defect and responsive to combined anti-tumour necrosis factor-α and interleukin-12/23 blockade. Br J Dermatol. 2022; 186(6):1026-1029. DOI: 10.1111/bjd.20978. View

13.

Mossner R, Wilsmann-Theis D, Oji V, Gkogkolou P, Lohr S, Schulz P . The genetic basis for most patients with pustular skin disease remains elusive. Br J Dermatol. 2017; 178(3):740-748. DOI: 10.1111/bjd.15867. View

14.

Johnston A, Xing X, Wolterink L, Barnes D, Yin Z, Reingold L . IL-1 and IL-36 are dominant cytokines in generalized pustular psoriasis. J Allergy Clin Immunol. 2017; 140(1):109-120. PMC: 5494022. DOI: 10.1016/j.jaci.2016.08.056. View

15.

Allingham R, Seo B, Rampersaud E, Bembe M, Challa P, Liu N . A duplication in chromosome 4q35 is associated with hereditary benign intraepithelial dyskeratosis. Am J Hum Genet. 2001; 68(2):491-4. PMC: 1235282. DOI: 10.1086/318194. View

16.

Hiraiwa T, Yamamoto T . Nail involvement associated with palmoplantar pustulosis. Int J Dermatol. 2016; 56(2):e28-e29. DOI: 10.1111/ijd.13224. View

17.

Evavold C, Kagan J . How Inflammasomes Inform Adaptive Immunity. J Mol Biol. 2017; 430(2):217-237. PMC: 5766381. DOI: 10.1016/j.jmb.2017.09.019. View

18.

Del Bel K, Ragotte R, Saferali A, Lee S, Vercauteren S, Mostafavi S . JAK1 gain-of-function causes an autosomal dominant immune dysregulatory and hypereosinophilic syndrome. J Allergy Clin Immunol. 2017; 139(6):2016-2020.e5. DOI: 10.1016/j.jaci.2016.12.957. View

19.

Sugiura K, Takeichi T, Kono M, Ogawa Y, Shimoyama Y, Muro Y . A novel IL36RN/IL1F5 homozygous nonsense mutation, p.Arg10X, in a Japanese patient with adult-onset generalized pustular psoriasis. Br J Dermatol. 2012; 167(3):699-701. DOI: 10.1111/j.1365-2133.2012.10953.x. View

20.

Kanatani Y, Shinkuma S, Matsumoto Y, Mitsui Y, Shobatake C, Ogawa K . Recurrence of impetigo herpetiformis carrying compound heterozygous mutations in IL36RN after remission with secukinumab. J Dermatol. 2021; 49(3):e108-e110. DOI: 10.1111/1346-8138.16247. View